Inotiv (NASDAQ:NOTV – Get Free Report) and OmniAb (NASDAQ:OABI – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Risk and Volatility Inotiv has a beta of 2.43, […]
Inotiv (NASDAQ:NOTV – Get Rating) and bioAffinity Technologies (NASDAQ:BIAF – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Insider & Institutional Ownership 52.1% of Inotiv shares are owned […]
Introduction
Cocaine use during pregnancy can affect fetal brain development. A fetal brain injury could happen from the direct effect of cocaine on the developing brain or from the reduction of placental perfusion from vasoconstriction, which may lead to hypoxia-ischemia. A potential mechanism for brain injury could be due to a neurotransmitter imbalance within the brain, especially glutamate. In an immature rat brain synaptosome model, we explored the additive effect of cocaine alone on glutamate release and the effect of cocaine combined with simulated hypoxic depolarization using potassium as a surrogate.
Method
Rat pups' brains were dissected and placed on a chilled petri dish. They then entered the experimental protocol. The suspended synaptosomes were divided equally into four experimental groups (control, high potassium "surrogate to hypoxic stimulation," cocaine, and cocaine + high K). Reversed-phase high-performance liquid chromatography analyzed glutam
Growth-Oriented Private Equity Firm SFW Partners with Leading Bioanalytical CRO to Drive Growth Through Expansion of Service Offering and Strategic AcquisitionsRYE, N.Y. (BUSINESS WIRE) SFW Capital Partners (“SFW”), a specialized private equity firm focused on partnering with leading founder- and family-owned comp.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the Europe early toxicity testing market.